CLINICAL_TRIALS
trial_result
· 2023-05-06
Clinical Trial Update: Neurosteroids in PTSD - Biomarkers to Therapeutics [Phase 2]
Summary
Phase 2 clinical trial investigating neurosteroids as biomarkers and therapeutics for posttraumatic stress disorder was terminated; results posted in 2023.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: VA Office of Research and Development | Conditions: Posttraumatic Stress Disorder | Phase 2 | Status: TERMINATED | Results posted: 2023-05-06